3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
34
Thoracic
6
Gastrointestinal
6
Dermatologic
6
Gynecologic
4
Genitourinary
4
Breast
4
Lymphoid
3
CNS
2
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
Other
1
NET
1
Myeloid
1
Endocrine
1
Conditions
Leukemia, Myeloid, Acute
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Myelodysplastic Syndromes
4
Myeloproliferative Disorders
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Waldenstrom Macroglobulinemia
2
Thrombocythemia, Essential
2
Primary Myelofibrosis
2
Polycythemia Vera
2
Neoplasms
2
Myelodysplastic-Myeloproliferative Diseases
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia
2
Congenital Abnormalities
2
Blast Crisis
2
Anemia, Refractory, with Excess of Blasts
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Interventions
motexafin gadolinium
1
Quality of Life
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Immunotherapy
1
Drug Therapy
1
Doxorubicin
1
Biological Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Drug Therapy
×
Myeloid
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled